Genicular Artery Embolization: A Promising Treatment Option for Recurrent Effusion Following Total Knee Arthroplasty.
effusion
embolization
genicular artery embolization
interventional radiologist
recurrent hemarthrosis
total knee arthroplasty
Journal
HSS journal : the musculoskeletal journal of Hospital for Special Surgery
ISSN: 1556-3316
Titre abrégé: HSS J
Pays: United States
ID NLM: 101273938
Informations de publication
Date de publication:
Nov 2024
Nov 2024
Historique:
received:
08
02
2023
accepted:
26
05
2023
pmc-release:
01
11
2025
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
ppublish
Résumé
Selective genicular artery embolization (GAE) has shown promise as a minimally invasive treatment option for persistent symptomatic recurrent effusions (REs) following total knee arthroplasty (TKA). We sought to investigate the radiographic and clinical success of GAE for RE after TKA. We performed a retrospective review of prospectively collected data on primary and revision TKA patients with RE, both hemorrhagic and non-hemorrhagic, who underwent GAE between 2019 and 2021 with a minimum of 6-month follow-up. All embolization procedures were performed by a single interventional radiologist. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and visual analog scale (VAS) scores were collected prior to GAE and at 1, 3, and 6 months post-procedure. Recurrence of effusion following GAE was assessed at 6 months using ultrasound. Seventeen patients, 10 female and 7 male, with 18 TKAs and a mean (SD) age of 63.1 (8.6) years were included. We saw a mean (SD) of 36.1 (24.4) and 3.3 (3.0) point improvement in WOMAC and VAS scores, respectively. In addition, 14 of the 18 TKAs (77.8%) seen at final follow-up had complete resolution of effusion confirmed by ultrasound. Our retrospective review found that a majority of patients showed significant clinical improvement and resolution of effusion following GAE. These findings suggest that GAE may be an effective minimally invasive treatment option for RE following TKA and should be further investigated.
Sections du résumé
Background
UNASSIGNED
Selective genicular artery embolization (GAE) has shown promise as a minimally invasive treatment option for persistent symptomatic recurrent effusions (REs) following total knee arthroplasty (TKA).
Purpose
UNASSIGNED
We sought to investigate the radiographic and clinical success of GAE for RE after TKA.
Methods
UNASSIGNED
We performed a retrospective review of prospectively collected data on primary and revision TKA patients with RE, both hemorrhagic and non-hemorrhagic, who underwent GAE between 2019 and 2021 with a minimum of 6-month follow-up. All embolization procedures were performed by a single interventional radiologist. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and visual analog scale (VAS) scores were collected prior to GAE and at 1, 3, and 6 months post-procedure. Recurrence of effusion following GAE was assessed at 6 months using ultrasound.
Results
UNASSIGNED
Seventeen patients, 10 female and 7 male, with 18 TKAs and a mean (SD) age of 63.1 (8.6) years were included. We saw a mean (SD) of 36.1 (24.4) and 3.3 (3.0) point improvement in WOMAC and VAS scores, respectively. In addition, 14 of the 18 TKAs (77.8%) seen at final follow-up had complete resolution of effusion confirmed by ultrasound.
Conclusion
UNASSIGNED
Our retrospective review found that a majority of patients showed significant clinical improvement and resolution of effusion following GAE. These findings suggest that GAE may be an effective minimally invasive treatment option for RE following TKA and should be further investigated.
Identifiants
pubmed: 39479505
doi: 10.1177/15563316231183971
pii: 10.1177_15563316231183971
pmc: PMC11520021
doi:
Types de publication
Journal Article
Langues
eng
Pagination
508-514Informations de copyright
© The Author(s) 2023.
Déclaration de conflit d'intérêts
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ZDP reports relationships with Orthodevelopment and Depuy. DYP reports relationships with Depuy. ACO reports relationships with Smith and Nephew and Stryker. The other authors declared no potential conflicts of interest.